Dyer & Berens LLP Announces November 20, 2009 Lead Plaintiff Deadline in Class Action Lawsuit Filed on Behalf of Certain Investors Who Purchased or Acquired Psychiatric Solutions, Inc. Common Stock - PSYS

If you purchased or otherwise acquired PSYS shares during the Class Period, you may, no later than November 20, 2009, request that the court appoint you as a lead plaintiff for the class. A lead plaintiff is a class member that acts on behalf of other investors in directing the litigation. Members of the putative class may seek appointment through counsel of their choice, or may choose to do nothing and remain absent class members. Although investors' ability to share in any recovery is not affected by their decision to seek appointment, lead plaintiffs make important decisions which could affect the overall recovery for class members.

For a free consultation regarding your rights and interests as a member of the putative class, you may contact Jeffrey A. Berens, Esq. at (888) 300-3362, (303) 861-1764, or via email at jeff@dyerberens.com.

The complaint charges that Psychiatric Solutions and certain of its officers and directors violated the federal securities laws. Specifically, defendants allegedly issued materially false statements concerning the company's safeguards and controls over its operations, including at its Riveredge Hospital facility. Defendants downplayed incidents at the company's facilities and falsely assured investors that corrective actions had already been taken to improve the quality, safety and risk management. Additionally, defendants allegedly issued materially false statements regarding the company's financial results.

To review a copy of the complaint, please contact Dyer & Berens LLP via telephone or email, or go to our website at www.DyerBerens.com. While the firm did not file the initial complaint in this matter, it specializes in complex class action litigation on behalf of injured investors throughout the nation. The firm's extensive experience in securities litigation, particularly in cases brought under the Private Securities Litigation Reform Act, has contributed to the recovery of hundreds of millions of dollars for aggrieved investors.